Cargando…

Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer

BACKGROUND: Doppler ultrasonography (US) is increasingly being utilized as an imaging modality in breast cancer. It is used to study the vascular characteristics of the tumor. Neoadjuvant chemotherapy is the standard modality of treatment in locally advanced breast cancer. Histological examination r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Anand, Singh, Seema, Pradhan, Satyajit, Shukla, Ram C, Ansari, Mumtaz A, Singh, Tej B, Shyam, Rohit, Gupta, Saroj
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008196/
https://www.ncbi.nlm.nih.gov/pubmed/17725837
http://dx.doi.org/10.1186/1477-7819-5-99
_version_ 1782135865798033408
author Kumar, Anand
Singh, Seema
Pradhan, Satyajit
Shukla, Ram C
Ansari, Mumtaz A
Singh, Tej B
Shyam, Rohit
Gupta, Saroj
author_facet Kumar, Anand
Singh, Seema
Pradhan, Satyajit
Shukla, Ram C
Ansari, Mumtaz A
Singh, Tej B
Shyam, Rohit
Gupta, Saroj
author_sort Kumar, Anand
collection PubMed
description BACKGROUND: Doppler ultrasonography (US) is increasingly being utilized as an imaging modality in breast cancer. It is used to study the vascular characteristics of the tumor. Neoadjuvant chemotherapy is the standard modality of treatment in locally advanced breast cancer. Histological examination remains the gold standard to assess the chemotherapy response. However, based on the color Doppler findings, a new scoring system that could predict histological response following chemotherapy is proposed. METHODS: Fifty cases of locally advanced infiltrating duct carcinoma of the breast were studied. The mean age of the patients was 44.5 years. All patients underwent clinical, Doppler and histopathological assessment followed by three cycles of CAF (Cyclophosphamide, Adriamycin and 5-Fluorouracil) chemotherapy, repeat clinical and Doppler examination and surgery. The resected specimens were examined histopathologically and histological response was correlated with Doppler findings. The Doppler characteristics of the tumor were graded as 1–4 for <25%, 25–50%, >50% and complete disappearance of flow signals respectively. A cumulative score was calculated and compared with histopathological response. Results were analyzed using Chi square test, sensitivity, specificity, positive and negative predictive values. RESULTS: The maximum Doppler score according to the proposed scoring system was twelve and minimum three. Higher scores corresponded with a more favorable histopathological response. Twenty four patients had complete response to chemotherapy. Sixteen of these 24 patients (66.7%) had a cumulative Doppler score more than nine. The sensitivity of cumulative score >5 was 91.7% and specificity was 38.5%. The area under the ROC curve of the cumulative score >9 was 0.72. CONCLUSION: Doppler scoring can be accurately used to objectively predict the response to chemotherapy in patients with locally advanced breast cancer and it correlates well with histopathological response.
format Text
id pubmed-2008196
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20081962007-10-10 Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer Kumar, Anand Singh, Seema Pradhan, Satyajit Shukla, Ram C Ansari, Mumtaz A Singh, Tej B Shyam, Rohit Gupta, Saroj World J Surg Oncol Technical Innovations BACKGROUND: Doppler ultrasonography (US) is increasingly being utilized as an imaging modality in breast cancer. It is used to study the vascular characteristics of the tumor. Neoadjuvant chemotherapy is the standard modality of treatment in locally advanced breast cancer. Histological examination remains the gold standard to assess the chemotherapy response. However, based on the color Doppler findings, a new scoring system that could predict histological response following chemotherapy is proposed. METHODS: Fifty cases of locally advanced infiltrating duct carcinoma of the breast were studied. The mean age of the patients was 44.5 years. All patients underwent clinical, Doppler and histopathological assessment followed by three cycles of CAF (Cyclophosphamide, Adriamycin and 5-Fluorouracil) chemotherapy, repeat clinical and Doppler examination and surgery. The resected specimens were examined histopathologically and histological response was correlated with Doppler findings. The Doppler characteristics of the tumor were graded as 1–4 for <25%, 25–50%, >50% and complete disappearance of flow signals respectively. A cumulative score was calculated and compared with histopathological response. Results were analyzed using Chi square test, sensitivity, specificity, positive and negative predictive values. RESULTS: The maximum Doppler score according to the proposed scoring system was twelve and minimum three. Higher scores corresponded with a more favorable histopathological response. Twenty four patients had complete response to chemotherapy. Sixteen of these 24 patients (66.7%) had a cumulative Doppler score more than nine. The sensitivity of cumulative score >5 was 91.7% and specificity was 38.5%. The area under the ROC curve of the cumulative score >9 was 0.72. CONCLUSION: Doppler scoring can be accurately used to objectively predict the response to chemotherapy in patients with locally advanced breast cancer and it correlates well with histopathological response. BioMed Central 2007-08-28 /pmc/articles/PMC2008196/ /pubmed/17725837 http://dx.doi.org/10.1186/1477-7819-5-99 Text en Copyright © 2007 Kumar et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Innovations
Kumar, Anand
Singh, Seema
Pradhan, Satyajit
Shukla, Ram C
Ansari, Mumtaz A
Singh, Tej B
Shyam, Rohit
Gupta, Saroj
Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
title Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
title_full Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
title_fullStr Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
title_full_unstemmed Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
title_short Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
title_sort doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
topic Technical Innovations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008196/
https://www.ncbi.nlm.nih.gov/pubmed/17725837
http://dx.doi.org/10.1186/1477-7819-5-99
work_keys_str_mv AT kumaranand dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer
AT singhseema dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer
AT pradhansatyajit dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer
AT shuklaramc dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer
AT ansarimumtaza dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer
AT singhtejb dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer
AT shyamrohit dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer
AT guptasaroj dopplerultrasoundscoringtopredictchemotherapeuticresponseinadvancedbreastcancer